Comparative analysis of iron homeostasis in sub-Saharan African children with sickle cell disease and their unaffected siblings

Frontiers in Pediatrics

Volumn 4, Issue FEB, 2016, Pages

  Gomez, Selma ^a   Diawara, Aïssatou ^b   Gbeha, Elias ^c   Awadalla, Philip ^c   Sanni, Ambaliou ^a   Idaghdour, Youssef ^b   Rahimy, M Cherif ^a  

^a UNIVERSITY OF ABOMEY CALAVI   (Benin)

^b NEW YORK UNIVERSITY ABU DHABI   (United Arab Emirates)

^c UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Anemia; Hepcidin; Iron deficiency; Iron homeostasis; Red blood cell indices; Serum iron proteins; Sickle cell disease

Indexed keywords

EID: 85048763170     PISSN: None     EISSN: 22962360     Source Type: Journal    
DOI: 10.3389/fped.2016.00008     Document Type: Article

References (48)

1. Serjeant GR. Sickle-cell disease. Lancet (1997) 350:725-30. doi:10.1016/S0140-6736(97)07330-3
2. Piel FB, Hay SI, Gupta S, Weatherall DJ, Williams TN. Global burden of sickle cell anaemia in children under five, 2010-2050: modelling based on demographics, excess mortality, and interventions. PLoS Med (2013) 10:e1001484. doi:10.1371/journal.pmed.1001484
3. Rahimy MC, Gangbo A, Ahouignan G, Alihonou E. Newborn screening for sickle cell disease in the Republic of Benin. J Clin Pathol (2009) 62:46-8. doi:10.1136/jcp.2008.059113
4. Hercberg S, Chauliac M, Galan P, Devanlay M, Zohoun I, Agboton Y, et al. Prevalence of iron deficiency and iron-deficiency anaemia in Benin. Public Health (1988) 102:73-83. doi:10.1016/S0033-3506(88)80013-1
5. Rahimy MC, Fanou L, Somasse YE, Gangbo A, Ahouignan G, Alihonou E. When to start supplementary iron to prevent iron deficiency in early childhood in sub-Saharan Africa setting. Pediatr Blood Cancer (2007) 48:544-9. doi:10.1002/pbc.21103
6. Joshi RS, Moran E, Sanchez M. Cellular Iron Metabolism. The IRP/IRE Regulatory Network. Iron Metabolism. Barcelona: InTech (2012)
7. Abbaspour N, Hurrell R, Kelishadi R. Review on iron and its importance for human health. J Res Med Sci (2014) 19:164-74
8. Onabanjo OO, Jerling JC, Covic N, Van Graan A, Taljaard C, Mamabolo RL. Association between iron status and white blood cell counts in African schoolchildren of the North-West Province, South Africa. J Epidemiol Glob Health (2012) 2:103-10. doi:10.1016/j.jegh.2012.07.003
9. Subramaniam G, Girish M. Iron deficiency anemia in children. Indian J Pediatr (2015) 82(6):558-64. doi:10.1007/s12098-014-1643-9
10. Fleming RE, Ponka P. Iron overload in human disease. N Engl J Med (2012) 366:348-59. doi:10.1056/NEJMra1004967
11. Siddique A, Kowdley KV. Review article: the iron overload syndromes. Aliment Pharmacol Ther (2012) 35:876-93. doi:10.1111/j.1365-2036.2012.05051.x
12. Arora S, Kapoor RK. Iron metobolism in humans: an overview. In: Arora S, editor. Iron Metabolism. Basaidarapur: InTech (2012). 186 p
13. Ganz T, Nemeth E. Iron metabolism: interactions with normal and disordered erythropoiesis. Cold Spring Harb Perspect Med (2012) 2:a011668. doi:10.1101/cshperspect.a011668
14. Wang J, Pantopoulos K. Regulation of cellular iron metabolism. Biochem J (2011) 434:365-81. doi:10.1042/BJ20101825
15. Nicolas G, Vaulont S. [Deciphering the action mechanism of hepcidin]. Med Sci (Paris) (2005) 21:7-9. doi:10.1051/medsci/20052117
16. Ganz T, Nemeth E. Hepcidin and iron homeostasis. Biochim Biophys Acta (2012) 1823:1434-43. doi:10.1016/j.bbamcr.2012.01.014
17. Ganz T. Systemic iron homeostasis. Physiol Rev (2013) 93:1721-41. doi:10.1152/physrev.00008.2013
18. Lee PL, Halloran C, Trevino R, Felitti V, Beutler E. Human transferrin G277S mutation: a risk factor for iron deficiency anaemia. Br J Haematol (2001) 115:329-33. doi:10.1046/j.1365-2141.2001.03096.x
19. Kasvosve I, Delanghe JR, Gomo ZA, Gangaidzo IT, Khumalo H, Wuyts B, et al. Transferrin polymorphism influences iron status in blacks. Clin Chem (2000) 46:1535-9
20. Rahimy MC, Gangbo A, Ahouignan G, Adjou R, Deguenon C, Goussanou S, et al. Effect of a comprehensive clinical care program on disease course in severely ill children with sickle cell anemia in a sub-Saharan African setting. Blood (2003) 102:834-8. doi:10.1182/blood-2002-05-1453
21. Oustamanolakis P, Koutroubakis IE, Messaritakis I, Niniraki M, Kouroumalis EA. Soluble transferrin receptor-ferritin index in the evaluation of anemia in inflammatory bowel disease: a case-control study. Ann Gastroenterol (2011) 24:108-14
22. Infusino I, Braga F, Dolci A, Pantheghini M. Soluble transferrin receptor (sTfR) and sTfR/log ferritin index for the diagnosis of iron-deficiency anemia. A meta-analysis. Am J Clin Pathol (2012) 138:642-9. doi:10.1309/AJCP16NTXZLZFAIB
23. WHO. Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity. Geneva: World Health Organization (2011). 6 p
24. Valavi E, Ansari MJ, Zandian K. How to reach rapid diagnosis in sickle cell disease? Iran J Pediatr (2010) 20:69-74
25. Akodu SO, Kehinde OA, Diaku-Akinwumi IN, Njokanma OF. Iron deficiency anaemia among pre-school children with sickle cell anaemia: still a rare diagnosis? Mediterr J Hematol Infect Dis (2013) 5:e2013069. doi:10.4084/MJHID.2013.069
26. Bhukhanvala DS, Sorathiya SM, Shah AP, Patel AG, Gupte SC. Prevalence and hematological profile of beta-thalassemia and sickle cell anemia in four communities of Surat city. Indian J Hum Genet (2012) 18:167-71. doi:10.4103/0971-6866.100752
27. Payandeh M, Rahimi Z, Zare ME, Kansestani AN, Gohardehi F, Hashemian AH. The prevalence of anemia and hemoglobinopathies in the hematologic clinics of the kermanshah province, Western iran. Int J Hematol Oncol Stem Cell Res (2014) 8:33-7
28. Coyne D. Iron indices: what do they really mean? Kidney Int Suppl (2006):S4-8. doi:10.1038/sj.ki.5000404
29. Berlin T, Meyer A, Rotman-Pikielny P, Natur A, Levy Y. Soluble transferrin receptor as a diagnostic laboratory test for detection of iron deficiency anemia in acute illness of hospitalized patients. Isr Med Assoc J (2011) 13:96-8
30. Finch C. Regulators of iron balance in humans. Blood (1994) 84:1697-702
31. Theil EC. Regulation of ferritin and transferrin receptor mRNAs. J Biol Chem (1990) 265:4771-4
32. Eisenstein RS, Blemings KP. Iron regulatory proteins, iron responsive elements and iron homeostasis. J Nutr (1998) 128:2295-8
33. Walter PB, Harmatz P, Vichinsky E. Iron metabolism and iron chelation in sickle cell disease. Acta Haematol (2009) 122:174-83. doi:10.1159/000243802
34. Porter J, Garbowski M. Consequences and management of iron overload in sickle cell disease. Hematology Am Soc Hematol Educ Program (2013) 2013:447-56. doi:10.1182/asheducation-2013.1.447
35. Ray D, Mondal R, Chakravarty UK, Burman DR. Assessment of iron status in patient of sickle cell disease and trait and its relationship with the frequency of blood transfusion in paediatric patients attending at B.S. Medical College & Hospital, Bankura, West Bengal, India. Int J Sci (2014) 2:37-9
36. Tripette J, Connes P, Hedreville M, Etienne-Julan M, Marlin L, Hue O, et al. Patterns of exercise-related inflammatory response in sickle cell trait carriers. Br J Sports Med (2010) 44:232-7. doi:10.1136/bjsm.2008.047530
37. Faes C, Balayssac-Siransy E, Connes P, Hivert L, Danho C, Bogui P, et al. Moderate endurance exercise in patients with sickle cell anaemia: effects on oxidative stress and endothelial activation. Br J Haematol (2014) 164:124-30. doi:10.1111/bjh.12594
38. Kearney SL, Nemeth E, Neufeld EJ, Thapa D, Ganz T, Weinstein DA, et al. Urinary hepcidin in congenital chronic anemias. Pediatr Blood Cancer (2007) 48:57-63. doi:10.1002/pbc.20616
39. Kroot JJ, Laarakkers CM, Kemna EH, Biemond BJ, Swinkels DW. Regulation of serum hepcidin levels in sickle cell disease. Haematologica (2009) 94:885-7. doi:10.3324/haematol.2008.003152
40. Weinstein DA, Roy CN, Fleming MD, Loda MF, Wolfsdorf JI, Andrews NC. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood (2002) 100:3776-81. doi:10.1182/blood-2002-04-1260
41. Finberg KE, Heeney MM, Campagna DR, Aydinok Y, Pearson HA, Hartman KR, et al. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat Genet (2008) 40:569-71. doi:10.1038/ng.130
42. Boelaert JR, Vandecasteele SJ, Appelberg R, Gordeuk VR. The effect of the host's iron status on tuberculosis. J Infect Dis (2007) 195:1745-53. doi:10.1086/518040
43. Schaible UE, Kaufmann SH. Iron and microbial infection. Nat Rev Microbiol (2004) 2:946-53. doi:10.1038/nrmicro1046
44. Sazawal S, Black RE, Ramsan M, Chwaya HM, Stoltzfus RJ, Dutta A, et al. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet (2006) 367:133-43. doi:10.1016/S0140-6736(06)67962-2
45. Drakesmith H, Prentice A. Viral infection and iron metabolism. Nat Rev Microbiol (2008) 6:541-52. doi:10.1038/nrmicro1930
46. Hyacinth HI, Gee BE, Hibbert JM. The role of nutrition in sickle cell disease. Nutr Metab Insights (2010) 3:57-67. doi:10.4137/NMI.S5048
47. Hibbert JM, Creary MS, Gee BE, Buchanan ID, Quarshie A, Hsu LL. Erythropoiesis and myocardial energy requirements contribute to the hypermetabolism of childhood sickle cell anemia. J Pediatr Gastroenterol Nutr (2006) 43:680-7. doi:10.1097/01.mpg.0000228120.44606.d6
48. Pelusi S, Girelli D, Rametta R, Campostrini N, Alfieri C, Traglia M, et al. The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients: TMPRSS6 and hepcidin in hemodialysis. BMC Nephrol (2013) 14:48. doi:10.1186/1471-2369-14-48